G3-R

Triple Hormone Receptor Agonist | GLP-1/GIP/Glucagon Research Compound

For Research Use Only. Not for human or veterinary use. Not a drug, supplement, or food additive.
Intended exclusively for in-vitro and laboratory research by qualified investigators.

Available Quantity: 10mg / 30mg  – A Triple Agonist of GLP-1, GIP, and Glucagon Receptors for Advanced Metabolic Research
Category: Peptide Research Compounds / Metabolic Research / Multi-Agonist Incretin Biology

Disclaimer

ATTENTION: PRIMALRESEARCHLABS.COM PRODUCTS ARE INTENDED FOR LABORATORY RESEARCH AND IN-VITRO STUDIES ONLY.

All information presented on this site is for educational and research purposes related to scientific investigation.
These products are strictly not for human or veterinary use, consumption, or diagnostic applications.
They are not pharmaceuticals, food additives, or dietary supplements.

By purchasing from PrimalResearchLabs.com, you acknowledge and affirm that you are a qualified researcher operating in a controlled laboratory environment. You must adhere to all applicable local, state, and federal laws and regulations regarding the handling and use of research chemicals. Handle all materials with appropriate personal protective equipment (PPE) and under laboratory safety protocols.

Biology

Retatrutide is a synthetic peptide engineered as a triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors.

This multi-agonist design enables coordinated modulation of metabolic pathways involved in glucose regulation, energy expenditure, and lipid metabolism.

Retatrutide has been extensively studied in preclinical and early clinical research models for its ability to simultaneously enhance insulin secretion, increase energy expenditure, and regulate appetite through central and peripheral mechanisms.

Its multi-receptor activity makes it a valuable tool for in-vitro and in-vivo experimental design across obesity research, metabolic disease modeling, and incretin biology.

This product is intended solely for in-vitro and preclinical research use and is not for human or veterinary consumption.

Key Research Applications of Retatrutide

1. Multi-Incretin Receptor Signaling & Metabolic Regulation Research

Retatrutide has demonstrated significant activity in metabolic studies through:

• GLP-1 & GIP Activation: Enhances insulin secretion and glucose regulation through incretin receptor pathways.
• Glucagon Receptor Modulation: Increases energy expenditure and lipid metabolism via glucagon signaling.
• Synergistic Hormonal Effects: Combines incretin and glucagon activity to produce integrated metabolic responses.

Supporting Studies:
Jastreboff, A.M. et al. — New England Journal of Medicine
“Triple-hormone receptor agonists demonstrate significant effects on body weight and metabolic regulation.”
PubMed – PMID: 37385278

2. Energy Expenditure & Weight Regulation Research

Retatrutide has been investigated in obesity and energy balance studies through:

• Appetite Suppression: Reduces food intake via central nervous system pathways.
• Increased Energy Expenditure: Promotes thermogenesis and metabolic rate enhancement.
• Weight Loss Mechanisms: Demonstrates significant reductions in body weight in experimental models.

Supporting Studies:
Finan, B. et al. — Nature Medicine
“Multi-agonist peptides targeting incretin and glucagon pathways improve metabolic outcomes.”
PubMed – PMID: 26280399

3. Glucose Homeostasis & Insulin Sensitivity Research

Retatrutide has been explored in glycemic control studies through:

• Improved Glucose Regulation: Enhances insulin sensitivity and glycemic stability.
• Pancreatic Function Support: Stimulates insulin secretion in response to glucose.
• Metabolic Disease Modeling: Used in studies of diabetes and insulin resistance pathways.

Supporting Studies:
Coskun, T. et al. — Molecular Metabolism
“GLP-1/GIP/glucagon receptor agonists improve glucose control and metabolic function.”
PubMed – PMID: 27777923

Recommended Research Concentrations

Note: For laboratory research reference only. Not for human or veterinary use.

Why Choose Primal Research for Your Retatrutide Research?

• ≥98% HPLC-verified purity — critical for multi-receptor signaling accuracy
• Independent third-party batch testing with COA available on request
• Lyophilized powder for maximum stability and long-term storage
• Available in 10mg, 20mg, and 40mg quantities — supports extensive metabolic research protocols

Storage & Handling

• Store at -20°C, desiccated and protected from light
• Soluble in sterile water or bacteriostatic water
• Prepare fresh solutions prior to each experiment
• Avoid repeated freeze-thaw cycles

Technical Specifications

• Compound: Retatrutide
• Purity: ≥98% (HPLC Verified)
• Form: Lyophilized powder — available in 10mg, 20mg, and 40mg
• Storage: -20°C, desiccated, light-protected
• Solubility: Soluble in sterile water or bacteriostatic water
• COA: Available per batch on request

Advance your research in incretin biology, energy metabolism, and multi-hormonal signaling systems by ordering Retatrutide today.

Final Disclaimer

Primal Research products are sold strictly for in-vitro and laboratory research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease or condition. Purchasers are responsible for compliance with all applicable local, state, and federal regulations.